BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2685695)

  • 21. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-dimensional phosphorus-31 chemical shift imaging of human brain tumors.
    Rutter A; Hugenholtz H; Saunders JK; Smith IC
    Invest Radiol; 1995 Jun; 30(6):359-66. PubMed ID: 7490188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma.
    Kim ES; Satter M; Reed M; Fadell R; Kardan A
    Neuroradiol J; 2016 Jun; 29(3):193-7. PubMed ID: 27122050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phosphorus-31 MR spectroscopy of brain tumors].
    Miyamachi K; Abe H; Miyasaka K
    No Shinkei Geka; 1990 Jun; 18(6):533-7. PubMed ID: 2395512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
    Morana G; Piccardo A; Puntoni M; Nozza P; Cama A; Raso A; Mascelli S; Massollo M; Milanaccio C; Garrè ML; Rossi A
    Neuro Oncol; 2015 Dec; 17(12):1637-47. PubMed ID: 26405202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
    Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
    Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
    No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
    Rozental JM; Levine RL; Nickles RJ
    J Neurooncol; 1991 Feb; 10(1):75-83. PubMed ID: 2022974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.
    Yamasaki F; Takayasu T; Nosaka R; Amatya VJ; Doskaliyev A; Akiyama Y; Tominaga A; Takeshima Y; Sugiyama K; Kurisu K
    J Neurosurg; 2015 Jun; 122(6):1370-9. PubMed ID: 25748300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
    Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
    No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR and positron emission tomography with fludeoxyglucose F 18 in gliomatosis cerebri.
    Dexter MA; Parker GD; Besser M; Ell J; Fulham MJ
    AJNR Am J Neuroradiol; 1995 Aug; 16(7):1507-10. PubMed ID: 7484643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.
    Takenaka S; Shinoda J; Asano Y; Aki T; Miwa K; Ito T; Yokoyama K; Iwama T
    Brain Tumor Pathol; 2011 Jul; 28(3):229-38. PubMed ID: 21442242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early metabolic changes following chemotherapy of human gliomas in vivo demonstrated by phosphorus magnetic resonance spectroscopy.
    Arnold DL; Shoubridge EA; Emrich J; Feindel W; Villemure JG
    Invest Radiol; 1989 Dec; 24(12):958-61. PubMed ID: 2606634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
    Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
    J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
    Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
    Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
    Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
    Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.